表紙
市場調查報告書
商品編碼
1020217

血糖監測系統的全球市場(2021年∼2025年)

Global Blood Glucose Monitoring Devices Market 2021-2025

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

血糖監測系統的市場規模在2021年∼2025年的預測期間內,預計將以8.16%的年複合成長率推移,並成長到58億4,000萬美元。

血糖監測系統市場相關之本報告提供整體分析,市場規模與預測,趨勢,涵括成長要素,課題,以及約25位供應商的供應商分析。

市場成長的主要因素有全球性糖尿病的負擔增加,血糖監測系統的技術的進步。

本報告提供血糖監測系統市場調查,提供市場概要,市場規模,市場預測,客戶形勢,各產品·各地區的分析,再加上業者情勢和供應商分析等資訊。

目錄

摘要整理

市場形勢

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2020年
  • 市場預測:從2020年∼2025年的預測

波特的五力分析

  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

各產品的市場區隔

  • 市場區隔
  • 各產品比較
  • SMBG:市場規模與預測(2020年∼2025年)
  • CGM:市場規模與預測(2020年∼2025年)
  • 採血針:市場規模與預測(2020年∼2025年)
  • 各產品的市場機會

客戶形勢

  • 客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美:市場規模與預測(2020年∼2025年)
  • 歐洲:市場規模與預測(2020年∼2025年)
  • 亞洲:市場規模與預測(2020年∼2025年)
  • 其他地區:市場規模與預測(2020年∼2025年)
  • 主要國家
  • 地區的市場機會
  • 市場成長促進因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 業者情勢
  • 創造性破壞狀況

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Abbott Laboratories
  • Agamatrix Inc.
  • ARKRAY Inc.
  • Ascensia Diabetes Care Holdings AG
  • Dexcom Inc.
  • F. Hoffmann La Roche Ltd.
  • Johnson and Johnson Inc.
  • Medtronic Plc
  • Terumo Europe NV
  • Trivida Health Inc.

附錄

目錄
Product Code: IRTNTR44338

Technavio has been monitoring the blood glucose monitoring devices market and it is poised to grow by $ 5.84 bn during 2021-2025, progressing at a CAGR of 8.16% during the forecast period. Our report on the blood glucose monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes and technological advances in BGM devices. In addition, the rising global burden of diabetes is anticipated to boost the growth of the market as well.

The blood glucose monitoring devices market analysis includes the product segment and geographic landscape.

Technavio's blood glucose monitoring devices market is segmented as below:

By Product

  • SMBG
  • CGM
  • Lancets

By Geography

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the availability of reimbursement for BGM devices as one of the prime reasons driving the blood glucose monitoring devices market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on blood glucose monitoring devices market covers the following areas:

  • Blood glucose monitoring devices market sizing
  • Blood glucose monitoring devices market forecast
  • Blood glucose monitoring devices market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood glucose monitoring devices market vendors that include Abbott Laboratories, Agamatrix Inc., ARKRAY Inc., Dexcom Inc., F. Hoffmann La Roche Ltd., Medtronic Plc, Johnson and Johnson Inc., Terumo Europe NV, Ascensia Diabetes Care Holdings AG, and Trivida Health Inc. Also, the blood glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Product
    • Market segments
    • Comparison by Product
    • SMBG - Market size and forecast 2020-2025
    • CGM - Market size and forecast 2020-2025
    • Lancets - Market size and forecast 2020-2025
    • Market opportunity by Product
  • Customer landscape
    • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Vendor landscape
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Abbott Laboratories
    • Agamatrix Inc.
    • ARKRAY Inc.
    • Ascensia Diabetes Care Holdings AG
    • Dexcom Inc.
    • F. Hoffmann La Roche Ltd.
    • Johnson and Johnson Inc.
    • Medtronic Plc
    • Terumo Europe NV
    • Trivida Health Inc.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: SMBG - Market size and forecast 2020-2025 ($ million)
  • 24: SMBG - Year-over-year growth 2020-2025 (%)
  • 25: CGM - Market size and forecast 2020-2025 ($ million)
  • 26: CGM - Year-over-year growth 2020-2025 (%)
  • 27: Lancets - Market size and forecast 2020-2025 ($ million)
  • 28: Lancets - Year-over-year growth 2020-2025 (%)
  • 29: Market opportunity by Product
  • 30: Customer landscape
  • 31: Market share by geography 2020-2025 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2020-2025 ($ million)
  • 34: North America - Year-over-year growth 2020-2025 (%)
  • 35: Europe - Market size and forecast 2020-2025 ($ million)
  • 36: Europe - Year-over-year growth 2020-2025 (%)
  • 37: Asia - Market size and forecast 2020-2025 ($ million)
  • 38: Asia - Year-over-year growth 2020-2025 (%)
  • 39: ROW - Market size and forecast 2020-2025 ($ million)
  • 40: ROW - Year-over-year growth 2020-2025 (%)
  • 41: Key leading countries
  • 42: Market opportunity by geography ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Abbott Laboratories - Overview
  • 50: Abbott Laboratories - Business segments
  • 51: Abbott Laboratories - Key offerings
  • 52: Abbott Laboratories - Key customers
  • 53: Abbott Laboratories - Segment focus
  • 54: Agamatrix Inc. - Overview
  • 55: Agamatrix Inc. - Product and service
  • 56: Agamatrix Inc. - Key offerings
  • 57: Agamatrix Inc. - Key customers
  • 58: Agamatrix Inc. - Segment focus
  • 59: ARKRAY Inc. - Overview
  • 60: ARKRAY Inc. - Product and service
  • 61: ARKRAY Inc. - Key offerings
  • 62: ARKRAY Inc. - Key customers
  • 63: ARKRAY Inc. - Segment focus
  • 64: Ascensia Diabetes Care Holdings AG - Overview
  • 65: Ascensia Diabetes Care Holdings AG - Product and service
  • 66: Ascensia Diabetes Care Holdings AG - Key offerings
  • 67: Ascensia Diabetes Care Holdings AG - Key customers
  • 68: Ascensia Diabetes Care Holdings AG - Segment focus
  • 69: Dexcom Inc. - Overview
  • 70: Dexcom Inc. - Business segments
  • 71: Dexcom Inc. - Key offerings
  • 72: Dexcom Inc. - Key customers
  • 73: Dexcom Inc. - Segment focus
  • 74: F. Hoffmann La Roche Ltd. - Overview
  • 75: F. Hoffmann La Roche Ltd. - Business segments
  • 76: F. Hoffmann La Roche Ltd. - Key offerings
  • 77: F. Hoffmann La Roche Ltd. - Key customers
  • 78: F. Hoffmann La Roche Ltd. - Segment focus
  • 79: Johnson and Johnson Inc. - Overview
  • 80: Johnson and Johnson Inc. - Business segments
  • 81: Johnson and Johnson Inc. - Key offerings
  • 82: Johnson and Johnson Inc. - Key customers
  • 83: Johnson and Johnson Inc. - Segment focus
  • 84: Medtronic Plc - Overview
  • 85: Medtronic Plc - Business segments
  • 86: Medtronic Plc - Key offerings
  • 87: Medtronic Plc - Key customers
  • 88: Medtronic Plc - Segment focus
  • 89: Terumo Europe NV - Overview
  • 90: Terumo Europe NV - Product and service
  • 91: Terumo Europe NV - Key offerings
  • 92: Terumo Europe NV - Key customers
  • 93: Terumo Europe NV - Segment focus
  • 94: Trivida Health Inc. - Overview
  • 95: Trivida Health Inc. - Product and service
  • 96: Trivida Health Inc. - Key offerings
  • 97: Trivida Health Inc. - Key customers
  • 98: Trivida Health Inc. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations